European ad-hoc consensus statement on gene replacement therapy for spinal muscular atrophy

Spinal muscular atrophy (SMA) used to be one of the most common genetic causes of infant mortality. New disease modifying treatments have changed the disease trajectories and most impressive results are seen if treatment is initiated in the presymptomatic phase of the disease. Very recently, the Eur...

Full description

Saved in:
Bibliographic Details
Main Authors: Kirschner, Janbernd (Author) , Butoianu, Nina (Author) , Goemans, Nathalie (Author) , Haberlova, Jana (Author) , Kostera-Pruszczyk, Anna (Author) , Mercuri, Eugenio (Author) , van der Pol, W. Ludo (Author) , Quijano-Roy, Susana (Author) , Sejersen, Thomas (Author) , Tizzano, Eduardo F. (Author) , Ziegler, Andreas (Author) , Servais, Laurent (Author) , Muntoni, Francesco (Author)
Format: Article (Journal)
Language:English
Published: 9 July 2020
In: European journal of paediatric neurology
Year: 2020, Volume: 28, Pages: 38-43
ISSN:1532-2130
DOI:10.1016/j.ejpn.2020.07.001
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ejpn.2020.07.001
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S1090379820301422
Get full text
Author Notes:Janbernd Kirschner, Nina Butoianu, Nathalie Goemans, Jana Haberlova, Anna Kostera-Pruszczyk, Eugenio Mercuri, W. Ludo van der Pol, Susana Quijano-Roy, Thomas Sejersen, Eduardo F. Tizzano, Andreas Ziegler, Laurent Servais, Francesco Muntoni

MARC

LEADER 00000caa a2200000 c 4500
001 1744296103
003 DE-627
005 20230428055614.0
007 cr uuu---uuuuu
008 210111s2020 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ejpn.2020.07.001  |2 doi 
035 |a (DE-627)1744296103 
035 |a (DE-599)KXP1744296103 
035 |a (OCoLC)1341385027 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kirschner, Janbernd  |d 1968-  |e VerfasserIn  |0 (DE-588)173047297  |0 (DE-627)697971783  |0 (DE-576)133899969  |4 aut 
245 1 0 |a European ad-hoc consensus statement on gene replacement therapy for spinal muscular atrophy  |c Janbernd Kirschner, Nina Butoianu, Nathalie Goemans, Jana Haberlova, Anna Kostera-Pruszczyk, Eugenio Mercuri, W. Ludo van der Pol, Susana Quijano-Roy, Thomas Sejersen, Eduardo F. Tizzano, Andreas Ziegler, Laurent Servais, Francesco Muntoni 
264 1 |c 9 July 2020 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 11.01.2021 
520 |a Spinal muscular atrophy (SMA) used to be one of the most common genetic causes of infant mortality. New disease modifying treatments have changed the disease trajectories and most impressive results are seen if treatment is initiated in the presymptomatic phase of the disease. Very recently, the European Medicine Agency approved Onasemnogene abeparvovec (Zolgensma®) for the treatment of patients with SMA with up to three copies of the SMN2 gene or the clinical presentation of SMA type 1. While this broad indication provides new opportunities, it also triggers discussions on the appropriate selection of patients in the context of limited available evidence. To aid the rational use of Onasemnogene abeparvovec for the treatment of SMA, a group of European neuromuscular experts presents in this paper eleven consensus statements covering qualification, patient selection, safety considerations and long-term monitoring. 
650 4 |a Gene therapy 
650 4 |a Nusinersen 
650 4 |a Onasemnogene abeparvovec 
650 4 |a SMN1 
650 4 |a SMN2 
650 4 |a Spinal muscular atrophy 
650 4 |a Zolgensma 
700 1 |a Butoianu, Nina  |e VerfasserIn  |4 aut 
700 1 |a Goemans, Nathalie  |e VerfasserIn  |4 aut 
700 1 |a Haberlova, Jana  |e VerfasserIn  |4 aut 
700 1 |a Kostera-Pruszczyk, Anna  |e VerfasserIn  |4 aut 
700 1 |a Mercuri, Eugenio  |e VerfasserIn  |4 aut 
700 1 |a van der Pol, W. Ludo  |e VerfasserIn  |4 aut 
700 1 |a Quijano-Roy, Susana  |e VerfasserIn  |4 aut 
700 1 |a Sejersen, Thomas  |e VerfasserIn  |4 aut 
700 1 |a Tizzano, Eduardo F.  |e VerfasserIn  |4 aut 
700 1 |a Ziegler, Andreas  |d 1979-  |e VerfasserIn  |0 (DE-588)134123530  |0 (DE-627)560894201  |0 (DE-576)278444253  |4 aut 
700 1 |a Servais, Laurent  |e VerfasserIn  |4 aut 
700 1 |a Muntoni, Francesco  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t European journal of paediatric neurology  |d [Oxford] : Elsevier, 1997  |g 28(2020), Seite 38-43  |h Online-Ressource  |w (DE-627)320475417  |w (DE-600)2009085-7  |w (DE-576)26776183X  |x 1532-2130  |7 nnas  |a European ad-hoc consensus statement on gene replacement therapy for spinal muscular atrophy 
773 1 8 |g volume:28  |g year:2020  |g pages:38-43  |g extent:6  |a European ad-hoc consensus statement on gene replacement therapy for spinal muscular atrophy 
856 4 0 |u https://doi.org/10.1016/j.ejpn.2020.07.001  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S1090379820301422  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210111 
993 |a Article 
994 |a 2020 
998 |g 134123530  |a Ziegler, Andreas  |m 134123530:Ziegler, Andreas  |d 910000  |d 910500  |e 910000PZ134123530  |e 910500PZ134123530  |k 0/910000/  |k 1/910000/910500/  |p 11 
999 |a KXP-PPN1744296103  |e 3834185469 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"title":[{"title_sort":"European journal of paediatric neurology","title":"European journal of paediatric neurology","subtitle":"ejpn ; official journal of the European Paediatric Neurology Society"}],"disp":"European ad-hoc consensus statement on gene replacement therapy for spinal muscular atrophyEuropean journal of paediatric neurology","type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 05.02.20"],"language":["eng"],"corporate":[{"display":"European Paediatric Neurology Society","roleDisplay":"Herausgebendes Organ","role":"isb"}],"recId":"320475417","pubHistory":["1.1997 -"],"part":{"year":"2020","pages":"38-43","text":"28(2020), Seite 38-43","volume":"28","extent":"6"},"origin":[{"publisherPlace":"[Oxford] ; Burlington, Mass.","publisher":"Elsevier ; Harcourt","dateIssuedKey":"2003","dateIssuedDisp":"2003-"}],"id":{"eki":["320475417"],"zdb":["2009085-7"],"issn":["1532-2130"]},"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"6 S."}],"id":{"doi":["10.1016/j.ejpn.2020.07.001"],"eki":["1744296103"]},"origin":[{"dateIssuedDisp":"9 July 2020","dateIssuedKey":"2020"}],"name":{"displayForm":["Janbernd Kirschner, Nina Butoianu, Nathalie Goemans, Jana Haberlova, Anna Kostera-Pruszczyk, Eugenio Mercuri, W. Ludo van der Pol, Susana Quijano-Roy, Thomas Sejersen, Eduardo F. Tizzano, Andreas Ziegler, Laurent Servais, Francesco Muntoni"]},"recId":"1744296103","language":["eng"],"note":["Gesehen am 11.01.2021"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title_sort":"European ad-hoc consensus statement on gene replacement therapy for spinal muscular atrophy","title":"European ad-hoc consensus statement on gene replacement therapy for spinal muscular atrophy"}],"person":[{"given":"Janbernd","family":"Kirschner","role":"aut","roleDisplay":"VerfasserIn","display":"Kirschner, Janbernd"},{"display":"Butoianu, Nina","roleDisplay":"VerfasserIn","role":"aut","family":"Butoianu","given":"Nina"},{"family":"Goemans","given":"Nathalie","display":"Goemans, Nathalie","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Jana","family":"Haberlova","role":"aut","roleDisplay":"VerfasserIn","display":"Haberlova, Jana"},{"given":"Anna","family":"Kostera-Pruszczyk","role":"aut","roleDisplay":"VerfasserIn","display":"Kostera-Pruszczyk, Anna"},{"family":"Mercuri","given":"Eugenio","display":"Mercuri, Eugenio","roleDisplay":"VerfasserIn","role":"aut"},{"given":"W. Ludo","family":"van der Pol","role":"aut","display":"van der Pol, W. Ludo","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Quijano-Roy, Susana","roleDisplay":"VerfasserIn","given":"Susana","family":"Quijano-Roy"},{"roleDisplay":"VerfasserIn","display":"Sejersen, Thomas","role":"aut","family":"Sejersen","given":"Thomas"},{"given":"Eduardo F.","family":"Tizzano","role":"aut","display":"Tizzano, Eduardo F.","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"Ziegler, Andreas","role":"aut","family":"Ziegler","given":"Andreas"},{"display":"Servais, Laurent","roleDisplay":"VerfasserIn","role":"aut","family":"Servais","given":"Laurent"},{"given":"Francesco","family":"Muntoni","role":"aut","roleDisplay":"VerfasserIn","display":"Muntoni, Francesco"}]} 
SRT |a KIRSCHNERJEUROPEANAD9202